Nuclear Data for Medical Isotopes

Session Organizer:
Syed M. Qaim, Forschungszentrum Juelich GmbH, Germany
Philip L. Cole, Idaho State University, United States

In recent years the use of radionuclides in medicine has been enhancing, both in diagnosis via tomographic studies (SPECT and PE) and in internal radionuclide therapy. Radioactive decay data play a key role in the choice of a radionuclide for a given application and nuclear reaction cross section data allow optimization of its production route, i.e. maximize the yield and minimize the radioactive impurity. In this Session it is planned to review the status of both types of data for important medical radionuclides as well as to outline future needs, especially with regard to production data. Most of the radionuclides are presently produced using a nuclear reactor or a medium-sized cyclotron. Recent work on standardization of production data of all commonly used diagnostic and therapeutic radionuclides will be presented. The data related to production at high energy-accelerators will be considered. Some recent attempts to produce a few radionuclides via photonuclear reactions using modern accelerators will be described and the status of the related data will be analyzed. The role of nuclear theory in understanding the various routes of production of radionuclides will be considered.


Predicting the production of medical isotopes with TALYS: The case of Tc-99m
Arjan J. Koning, Nuclear Research and Consultancy Group, NRG, The Netherlands

New developments on the experimental data for charged particle production of medical isotopes
F. Ditrói, Institute of Nuclear Research of the Hungarian Academy of Sciences, Hungary

Paucity of Photonuclear Data for the Accelerator-Based Production of Isotopes
Valeriia N. Starovoitova, Niowave, Inc., United States